REGENXBIO Inc.
- CIK: 0001590877
- EIN: 47-1851754
- Business address: 9804 MEDICAL CENTER DRIVE, ROCKVILLE, Maryland, 20850
About REGENXBIO Inc.
REGENXBIO Inc. (CIK: 0001590877) is an American company incorporated in the state of Maryland. Head office is located at 9804 MEDICAL CENTER DRIVE, ROCKVILLE, Maryland, 20850. Work in the industry 2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES). REGENXBIO Inc. is a public company and trade via Over-The-Counter (OTC).Old names:
- ReGenX Biosciences, LLC from 2013-07-Nov to 2013-07-Nov
Ownership
| Owner | Filings | Transaction Date | Type of Owner |
|---|---|---|---|
| Zachary Jennifer | 0001737231 | Jun-03-2022 | director |
| MIGAUSKY GEORGE V | 0001134365 | Sep-03-2021 | director |
| Bennett Jean | 0001872219 | Sep-03-2021 | director |
| PAKOLA STEVE | 0001700659 | Apr-17-2019 | officer: Chief Medical Officer |
| Glucksmann Alexandra | 0001658390 | May-25-2018 | director |
| Danos Olivier | 0001701180 | Mar-27-2017 | officer: Chief Scientific Officer |
| Christmas Patrick J. | 0001521123 | Aug-18-2016 | officer: Senior VP, General Counsel |
| Tasse Daniel | 0001502785 | Aug-15-2016 | director |
| Abdun-Nabi Daniel | 0001380187 | Aug-05-2016 | director |
| Ali Faraz | 0001667937 | Feb-29-2016 | officer: Chief Business Officer |
| STUMP DAVID C | 0001191235 | Oct-14-2015 | director |
| FMR LLC | 0000315066 | Sep-22-2015 | 10 percent owner, other: See Remark 1 |
| Deerfield Mgmt L.P. | 0001010823 | Sep-22-2015 | 10 percent owner, other: Possible Member of 10% Group |
| DEERFIELD PARTNERS, LP | 0001301041 | Sep-22-2015 | 10 percent owner, other: Possible Member of 10% Group |
| Deerfield International Master Fund, L.P. | 0001565089 | Sep-22-2015 | 10 percent owner, other: Possible Member of 10% Group |
| DEERFIELD MANAGEMENT CO | 0001009258 | Sep-16-2015 | 10 percent owner, other: Possible Member of 10% Group |
| KARABELAS ARGERIS N | 0001191229 | Sep-16-2015 | director |
| BESHAR LUKE M | 0001192128 | Sep-16-2015 | director |
| HAYDEN DONALD J JR | 0001202285 | Sep-16-2015 | director |
| ENGLEMAN EDGAR | 0001227162 | Sep-16-2015 | director |
| Simpson Curran | 0001346164 | Sep-16-2015 | officer: SVP of Technical Operations |
| Flynn James E | 0001352546 | Sep-16-2015 | 10 percent owner, other: Possible Member of 10% Group |
| Samuels Camille D | 0001354034 | Sep-16-2015 | director |
| Deerfield Private Design Fund III, L.P. | 0001603333 | Sep-16-2015 | 10 percent owner, other: Possible Member of 10% Group |
| Deerfield Mgmt III, L.P. | 0001610540 | Sep-16-2015 | 10 percent owner, other: Possible Member of 10% Group |
| Mills Kenneth T. | 0001652824 | Sep-16-2015 | director, officer: See Remarks |
| Yoo Stephen | 0001652825 | Sep-16-2015 | officer: Chief Medical Officer |
| Vasista Vittal | 0001652827 | Sep-16-2015 | officer: See Remarks |
| Fox Allan M. | 0001652936 | Sep-16-2015 | director, 10 percent owner |
Stock Chart
Coming soon!
Jobs
Coming soon!
Recent SEC Filings
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by REGENXBIO Inc.
| Filings | Format | Description | Filed/Effective | File/Film Number |
|---|---|---|---|---|
| 8-K | Document | Current report filing Acc-no: 0001193125-25-045585 (34 Act) Size: KB |
Mar-04-2025 | 25704264 |
| SCHEDULE 13G/A | Document | Acc-no: 0000019617-25-000259 (34 Act) Size: KB | Feb-12-2025 | 25614385 |
| SCHEDULE 13G | Document | Acc-no: 0000093751-25-000088 (34 Act) Size: KB | Feb-05-2025 | 25590931 |
| SCHEDULE 13G/A | Document | Acc-no: 0000932471-25-000211 (34 Act) Size: KB | Jan-31-2025 | 25576314 |
| 4/A | Document | Amendment to Statement of changes in beneficial ownership of securities Acc-no: 0001562180-25-000360 ( Act) Size: KB |
Jan-14-2025 | |
| 8-K | Document | Current report filing Acc-no: 0001193125-25-005659 (34 Act) Size: KB |
Jan-14-2025 | 25527747 |
| SCHEDULE 13G | Document | Acc-no: 0002012383-25-000047 (34 Act) Size: KB | Jan-08-2025 | 25519635 |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001562180-25-000190 ( Act) Size: 0 KB |
Jan-06-2025 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001562180-25-000189 ( Act) Size: 0 KB |
Jan-06-2025 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001562180-25-000188 ( Act) Size: 0 KB |
Jan-06-2025 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001562180-25-000187 ( Act) Size: 0 KB |
Jan-06-2025 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001562180-25-000186 ( Act) Size: 0 KB |
Jan-06-2025 | |
| 144 | Document | Filing for proposed sale of securities under Rule 144 Acc-no: 0001950047-24-010094 (33 Act) Size: 0 KB |
Dec-30-2024 | 241589838 |
| 424B5 | Document | Prospectus filed pursuant to Rule 424(b)(5) Acc-no: 0001193125-24-273517 (33 Act) Size: KB |
Dec-09-2024 | 241535974 |
| 8-K | Document | Current report filing Acc-no: 0001193125-24-273467 (34 Act) Size: KB |
Dec-09-2024 | 241535656 |
| SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001104659-24-119431 (34 Act) Size: KB |
Nov-14-2024 | 241465542 |
| SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000932471-24-001135 (34 Act) Size: KB |
Nov-12-2024 | 241449319 |
| 10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000950170-24-122330 (34 Act) Size: KB |
Nov-06-2024 | 241431157 |
| 8-K | Document | Current report filing Acc-no: 0000950170-24-122300 (34 Act) Size: KB |
Nov-06-2024 | 241431007 |
| SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000932471-24-000670 (34 Act) Size: KB |
Nov-04-2024 | 241422382 |
Recent 20 filings. View all REGENXBIO Inc. filings
Reviews
Ryan Storey
Huge help thank you for your help .. y'all make it so much easier
Jean Bishop
Very good communication and delivery made within the timeframe I was advised of
Pelisari
young lad who new his job ansered questions and new what was best for me.
Frequently Asked Questions
Tags:
- REGENXBIO Inc. overview
- REGENXBIO Inc. job
- REGENXBIO Inc. stock
- REGENXBIO Inc. ownership
- REGENXBIO Inc. CEO
- REGENXBIO Inc. documents
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
Orther Companies
Maze Therapeutics, Inc.
Update: Jan 08, 2025
Inhibrx Biosciences, Inc.
Update: Apr 26, 2024
CG Oncology, Inc.
Update: Jan 03, 2024
Iris Parent Holding Corp.
Update: Nov 09, 2023
Kyverna Therapeutics, Inc.
Update: Nov 08, 2023
Sequoia Vaccines, Inc.
Update: Nov 07, 2023
Latest News
SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate...
Charter Communications to Pay $25 Million Penalty for Unauthorized...
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries...
SEC Charges Royal Bank of Canada with Internal Accounting Controls...
SEC Charges President/CCO of Prophecy Asset Management Advisory...
SEC Adopts Rules for the Registration and Regulation of Security-Based...
SEC Charges Crypto Company SafeMoon and its Executive Team for...
© 2022 